JP2018509424A5 - - Google Patents

Download PDF

Info

Publication number
JP2018509424A5
JP2018509424A5 JP2017548170A JP2017548170A JP2018509424A5 JP 2018509424 A5 JP2018509424 A5 JP 2018509424A5 JP 2017548170 A JP2017548170 A JP 2017548170A JP 2017548170 A JP2017548170 A JP 2017548170A JP 2018509424 A5 JP2018509424 A5 JP 2018509424A5
Authority
JP
Japan
Prior art keywords
alkyl
alkenyl
alkynyl
cycloalkyl
aryl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2017548170A
Other languages
English (en)
Japanese (ja)
Other versions
JP2018509424A (ja
JP6676650B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2015/020397 external-priority patent/WO2016148674A1/en
Publication of JP2018509424A publication Critical patent/JP2018509424A/ja
Publication of JP2018509424A5 publication Critical patent/JP2018509424A5/ja
Application granted granted Critical
Publication of JP6676650B2 publication Critical patent/JP6676650B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2017548170A 2015-03-13 2015-03-13 疾患を処置するためのコンジュゲート Active JP6676650B2 (ja)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US2015/020397 WO2016148674A1 (en) 2015-03-13 2015-03-13 Conjugates for treating diseases

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2020043256A Division JP2020117509A (ja) 2020-03-12 2020-03-12 疾患を処置するためのコンジュゲート

Publications (3)

Publication Number Publication Date
JP2018509424A JP2018509424A (ja) 2018-04-05
JP2018509424A5 true JP2018509424A5 (enExample) 2018-05-24
JP6676650B2 JP6676650B2 (ja) 2020-04-08

Family

ID=56920017

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2017548170A Active JP6676650B2 (ja) 2015-03-13 2015-03-13 疾患を処置するためのコンジュゲート

Country Status (6)

Country Link
US (2) US10624972B2 (enExample)
EP (1) EP3268046A4 (enExample)
JP (1) JP6676650B2 (enExample)
CN (1) CN107847609A (enExample)
CA (1) CA2979527A1 (enExample)
WO (1) WO2016148674A1 (enExample)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3223860A4 (en) * 2014-11-25 2018-08-01 Endocyte, Inc. Methods of treating cancer by targeting tumor-associated macrophages
CN107847609A (zh) 2015-03-13 2018-03-27 恩多塞特公司 用于治疗疾病的缀合物
WO2017172930A1 (en) * 2016-03-29 2017-10-05 Endocyte, Inc. Pbd conjugates for treating diseases
CN109475558A (zh) * 2016-05-25 2019-03-15 普渡研究基金会 通过靶向骨髓衍生的抑制细胞而治疗癌症的方法
US11135307B2 (en) 2016-11-23 2021-10-05 Mersana Therapeutics, Inc. Peptide-containing linkers for antibody-drug conjugates
BR112022013008A2 (pt) 2019-12-31 2022-09-06 Legochem Biosciences Inc Composto derivado de pirrolobenzodiazepina, conjugado de derivado-ligante de pirrolobenzodiazepina, e, composição farmacêutica e método para prevenção ou tratamento de doença proliferativa

Family Cites Families (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS60255789A (ja) 1984-06-01 1985-12-17 Kyowa Hakko Kogyo Co Ltd マイトマイシン誘導体,その製造法および抗腫瘍剤
EP0457875A4 (en) 1989-11-13 1993-03-03 Xoma Corporation Chimeric mouse-human a10 antibody with specificity to a human tumor cell antigen
US5376645A (en) 1990-01-23 1994-12-27 University Of Kansas Derivatives of cyclodextrins exhibiting enhanced aqueous solubility and the use thereof
KR0166088B1 (ko) 1990-01-23 1999-01-15 . 수용해도가 증가된 시클로덱스트린 유도체 및 이의 용도
EP0547163B1 (en) 1990-08-29 2002-02-06 Centre Hospitalier Regional De Nantes Protein polyligands joined to a stable protein core
AUPN449295A0 (en) * 1995-07-28 1995-08-24 Inner And Eastern Health Care Network, The Radioprotectors
GB9518953D0 (en) 1995-09-15 1995-11-15 Pfizer Ltd Pharmaceutical formulations
WO2000035298A1 (en) 1996-11-27 2000-06-22 Wm. Wrigley Jr. Company Chewing gum containing medicament active agents
GB9711643D0 (en) 1997-06-05 1997-07-30 Janssen Pharmaceutica Nv Glass thermoplastic systems
GB9818731D0 (en) 1998-08-27 1998-10-21 Univ Portsmouth Compounds
US6822086B1 (en) 1999-08-09 2004-11-23 The General Hospital Corporation Drug-carrier complexes and methods of use thereof
JP4813712B2 (ja) * 1999-08-09 2011-11-09 ザ ジェネラル ホスピタル コーポレーション 薬物−担体複合体およびその使用方法
US7601332B2 (en) 2003-01-27 2009-10-13 Endocyte, Inc. Vitamin receptor binding drug delivery conjugates
RU2470668C2 (ru) * 2005-08-19 2012-12-27 Эндосайт, Инк. Конъюгаты лиганда с несколькими лекарственными средствами
CN101287500A (zh) * 2005-08-19 2008-10-15 恩多塞特公司 多药物配体缀合物
JP2010518128A (ja) 2007-02-16 2010-05-27 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング C型肝炎ns3プロテアーゼのインヒビター
BRPI0812970A2 (pt) * 2007-06-25 2019-09-24 Endocyte Inc conjugados contendo espaçadores hidrofílicos
JP5675619B2 (ja) 2008-09-17 2015-02-25 エンドサイト, インク.Endocyte, Inc. 葉酸拮抗薬の葉酸受容体結合性コンジュゲート
US20100074863A1 (en) * 2008-09-17 2010-03-25 Yat Sun Or Anti-infective pyrrolidine derivatives and analogs
PT2528625E (pt) * 2010-04-15 2013-10-17 Spirogen Sarl Pirrolobenzodiazepinas e conjugados das mesmas
RU2012154914A (ru) 2010-05-19 2014-06-27 Эндосайт, Инк. Улучшенный способ получения нацеленного на фолат средства
SI2675480T1 (sl) 2011-02-15 2019-05-31 Immunogen, Inc. Metode priprave konjugatov
CA2807712A1 (en) * 2012-03-01 2013-09-01 Purdue Research Foundation Methods for treating cancer
EA201590622A1 (ru) * 2012-10-16 2015-10-30 Эндосайт, Инк. Конъюгаты для доставки лекарственного средства, содержащие не встречающиеся в природе аминокислоты, и способы применения
KR102318999B1 (ko) * 2012-11-15 2021-10-29 엔도사이트, 인코포레이티드 Psma 발현 세포에 의해 야기되는 질병을 치료하기 위한 컨쥬게이트
US10131682B2 (en) * 2012-11-24 2018-11-20 Hangzhou Dac Biotech Co., Ltd. Hydrophilic linkers and their uses for conjugation of drugs to a cell binding molecules
US9567340B2 (en) 2012-12-21 2017-02-14 Medimmune Limited Unsymmetrical pyrrolobenzodiazepines-dimers for use in the treatment of proliferative and autoimmune diseases
SI3191135T1 (sl) 2014-09-12 2021-01-29 Genentech, Inc. Anti-HER2 protitelesa in imunokonjugati
EP3223860A4 (en) 2014-11-25 2018-08-01 Endocyte, Inc. Methods of treating cancer by targeting tumor-associated macrophages
CN107847609A (zh) 2015-03-13 2018-03-27 恩多塞特公司 用于治疗疾病的缀合物
WO2017172930A1 (en) 2016-03-29 2017-10-05 Endocyte, Inc. Pbd conjugates for treating diseases

Similar Documents

Publication Publication Date Title
JP2020525429A5 (enExample)
JP2025160318A5 (enExample)
JPWO2020130125A5 (enExample)
RU2012115851A (ru) Кристаллические формы и сольваты авт-263 для применения в лечении заболеваний, связанных с белком bcl-2
JP2018510850A5 (enExample)
RU2014151565A (ru) Способ получения n-[5-(3,5-дифторбензил)-1н-индазол-3-ил]-4-(4-метилпиперазин-1-ил)-2-(тетрагидропиран-4-иламино)бензамида
JP2020536091A5 (enExample)
JP2020517616A5 (enExample)
NZ701290A (en) Pyrrolobenzodiazepines
JP2017536344A5 (enExample)
JP2023545096A5 (enExample)
JP2018504379A5 (enExample)
JP2017528467A5 (enExample)
JP2007511504A5 (enExample)
JP2012516896A5 (enExample)
CY1116902T1 (el) Παραγωγα ισοξαζολο-πυριδινης
JP2011515397A5 (enExample)
JP2011509949A5 (enExample)
JP2017532360A5 (enExample)
JP2015502979A5 (enExample)
JP2018525399A5 (enExample)
JP2012509265A5 (enExample)
JP2021519262A5 (enExample)
EP3137074A1 (en) Prostaglandin receptor ep2 antagonists, derivatives, compositions, and uses related thereto
JP2023532591A (ja) 葉酸拮抗リンカー-薬物及び抗体-薬物複合体